| Renee Kathryn Brenengen, RPH | |
|
274 E 3rd St, Winona, MN 55987-3720 | |
| (507) 452-2547 | |
| (507) 452-4456 |
| Full Name | Renee Kathryn Brenengen |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 274 E 3rd St, Winona, Minnesota |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1396927505 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 10990 (Wisconsin) | Secondary |
| 183500000X | Pharmacist | 119163 (Minnesota) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Renee Kathryn Brenengen, RPH 274 E 3rd St, Winona, MN 55987-3720 Ph: (507) 452-2547 | Renee Kathryn Brenengen, RPH 274 E 3rd St, Winona, MN 55987-3720 Ph: (507) 452-2547 |
News Archive
Several Banner Health facilities in Arizona have received a prestigious stroke award in recognition of their ability to better diagnose and treat stroke patients, to reduce death and disability among patients and to speed recovery.
Faulty cell cycle "checkpoints" that fail to respond to DNA damage effectively may contribute to the high incidence of lung cancer in African-Americans, say researchers at Georgetown University's Lombardi Comprehensive Cancer Center and the National Cancer Institute (NCI).
Media outlets report on a range of health overhaul issues, including efforts in some states to use the sweeping measure for their own coverage expansion plans or to step up their oversight of the insurance industry.
C. R. Bard, Inc. today announced the publication of trial results by The New England Journal of Medicine (NEJM) showing the Bard FLAIR® Endovascular Stent Graft maintains the patency of dialysis access grafts more effectively than balloon angioplasty alone. The FLAIR® Endovascular Stent Graft is the only implant approved by the U.S. Food and Drug Administration for use in the treatment of stenoses at the venous anastomosis of ePTFE or other synthetic arteriovenous access grafts.
A medicine widely used to treat attention-deficit/hyperactivity disorder (ADHD) also provides long-term relief from the attention and behavior changes that affect many childhood cancer survivors, according to a multicenter trial led by St. Jude Children's Research Hospital investigators.
› Verified 2 days ago
Dr. Audra Lee Rinard, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1475 W Service Dr, Winona, MN 55987 Phone: 507-452-9002 Fax: 507-452-9592 | |
Dr. Timothy Rockey, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 955 Frontenac Dr, Winona, MN 55987 Phone: 507-452-0615 | |
Mr. John Paul Roche, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 274 E 3rd St, Winona, MN 55987 Phone: 507-452-2547 Fax: 507-452-4456 | |
Ms. Christine E. Clark, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1122 Hwy 61, Winona, MN 55987 Phone: 507-454-6072 | |
Mrs. Lori Mae Orchard, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 860 Mankato Ave, Winona, MN 55987 Phone: 507-858-3236 | |
Mr. Terence Michael Full, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 825 Mankato Ave, Winona, MN 55987 Phone: 507-454-4925 | |
Su Yamin Myat, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 750 Mankato Ave, Winona, MN 55987 Phone: 507-452-4076 |